Low-dose natural human interferon-alpha lozenges in the treatment of Behcet's syndrome
RHEUMATOLOGY, vol.48, no.11, pp.1388-1391, 2009 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 48 Issue: 11
- Publication Date: 2009
- Doi Number: 10.1093/rheumatology/kep237
- Journal Name: RHEUMATOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1388-1391
- Open Archive Collection: AVESIS Open Access Collection
- Istanbul University-Cerrahpasa Affiliated: No
Abstract
Objectives. There had been evidence that low-dose local IFN could be beneficial in the management of recurrent oral ulcers (OUs). We investigated the efficacy and collected initial data on the safety of low-dose natural human IFN-alpha administered by the oral mucosal route in Behcet's syndrome (BS) in a placebo controlled, double blind study.